Advertisement

Pediatric Surgery International

, Volume 34, Issue 2, pp 129–135 | Cite as

Characterization of M1 and M2 polarization of macrophages in vascularized human dermo-epidermal skin substitutes in vivo

  • Agnes S. KlarEmail author
  • Katarzyna Michalak-Mićka
  • Thomas Biedermann
  • Claudia Simmen-Meuli
  • Ernst Reichmann
  • Martin Meuli
Original Article

Abstract

Aims and objectives

Vascularized bio-engineered human dermo-epidermal skin substitutes (vascDESS) hold promise for treating burn patients, including those with severe full-thickness wounds. We have previously shown that vascDESS promote wound healing by enhanced influx of macrophages and granulocytes. Immediately following transplantation, macrophages infiltrate the graft and differentiate into a pro-inflammatory (M1) or a pro-healing M2 phenotype. The aim of this study was to characterize the activation state of macrophages infiltrating skin transplants at distinct time points following transplantation.

Methods

Keratinocytes and the stromal vascular fraction (SVF) were derived from human skin or adipose tissue, respectively. Human SVF containing both endothelial and mesenchymal/stromal cells was used to generate vascularized dermal component in vitro, which was subsequently covered with human keratinocytes. Finally, vascDESS were transplanted on the back of immuno-incompetent rats, excised, and analyzed after 1 and 3 weeks using immunohistological techniques.

Results

A panel of markers of macrophage M1 (nitric oxide synthase: iNOS) and M2 (CD206) subclass was used. All skin grafts were infiltrated by both M1 and M2 rat macrophages between 1–3 weeks post-transplantation. CD68 (PG-M1) was used as a pan-macrophage marker. The number of CD68+CD206+ M2-polarized macrophages was higher in 3-week transplants as compared to early-stage transplants (1 week). In contrast, the number of CD68+iNOS+ M1 cells was markedly decreased in later stages in vivo.

Conclusions

Macrophages exhibit a heterogeneous and temporally regulated polarization during skin wound healing. Our results suggest that the phenotype of macrophages changes during healing from a more pro-inflammatory (M1) profile in early stages after injury, to a less inflammatory, pro-healing (M2) phenotype in later phases in vivo.

Keywords

Macrophages Adipose stem cells Skin tissue engineering 

Notes

Acknowledgements

This work was financially supported by the EU-FP6 project EuroSTEC (soft tissue engineering for congenital birth defects in children: contract: LSHB-CT-2006-037409), by the EU-FP7 project EuroSkinGraft (FP7/2007–2013: Grant Agreement nr 279024), by the EU-FP7 (MultiTERM, Grant Agreement nr 238551), and the Clinical Research Priority Programs (CRPP) of the Faculty of Medicine of the University of Zurich. We are particularly grateful to the Gaydoul Foundation and the sponsors of “DonaTissue” (Thérèse Meier and Robert Zingg) for their generous financial support and interest in our work.

Compliance with ethical standards

Conflict of interest

E. R. and M. M. are co-founding members and shareholders of “Cutiss AG”, a company to fund the further development of the tissue engineered skin substitutes. All other authors declare that they have no conflict of interest.

References

  1. 1.
    Adamson R (2009) Role of macrophages in normal wound healing: an overview. J Wound Care 18:349–351CrossRefPubMedGoogle Scholar
  2. 2.
    Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746CrossRefPubMedGoogle Scholar
  3. 3.
    Martin P, Leibovich SJ (2005) Inflammatory cells during wound, repair: the good, the bad and the ugly. Trends Cell Biol 5:599–607CrossRefGoogle Scholar
  4. 4.
    Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585–601CrossRefPubMedGoogle Scholar
  6. 6.
    DiPietro LA (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4:233–240CrossRefPubMedGoogle Scholar
  7. 7.
    Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35CrossRefPubMedGoogle Scholar
  8. 8.
    Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057–1069CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Crane MJ, Daley JM, van Houtte O, Brancato SK, Henry WL Jr, Albina JE (2014) The monocyte to macrophage transition in the murine sterile wound. PLoS One 9:e86660CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Klar AS, Bottcher-Haberzeth S, Biedermann T, Michalak K, Kisiel M, Reichmann E, Meuli M (2014) Differential expression of granulocyte, macrophage, and hypoxia markers during early and late wound healing stages following transplantation of tissue-engineered skin substitutes of human origin. Pediatr Surg Int 30:1257–1264CrossRefPubMedGoogle Scholar
  11. 11.
    Klar AS, Guven S, Biedermann T, Luginbuhl J, Bottcher-Haberzeth S, Meuli-Simmen C, Meuli M, Martin I, Scherberich A, Reichmann E (2014) Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells. Biomaterials 35:5065–5078CrossRefPubMedGoogle Scholar
  12. 12.
    Klar AS, Bottcher-Haberzeth S, Biedermann T, Schiestl C, Reichmann E, Meuli M (2014) Analysis of blood and lymph vascularization patterns in tissue-engineered human dermo-epidermal skin analogs of different pigmentation. Pediatr Surg Int 30:223–231CrossRefPubMedGoogle Scholar
  13. 13.
    Klar AS, Biedermann T, Simmen-Meuli C, Reichmann E, Meuli M (2017) Comparison of in vivo immune responses following transplantation of vascularized and non-vascularized human dermo-epidermal skin substitutes. Pediatr Surg Int 33:377–382CrossRefPubMedGoogle Scholar
  14. 14.
    Lech M, Anders HJ (2013) Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. J Pharmacol Exp Ther 1832:989–997Google Scholar
  15. 15.
    Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964CrossRefPubMedGoogle Scholar
  16. 16.
    Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12:1035–1044CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rock KL, Lai JJ, Kono H (2011) Innate and adaptive immune responses to cell death. Immunol Rev 243:191–205CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ikezumi Y, Atkins RC, Nikolic-Paterson DJ (2003) Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 14:888–898CrossRefPubMedGoogle Scholar
  19. 19.
    Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ (2003) Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76:1015–1022CrossRefPubMedGoogle Scholar
  20. 20.
    Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22:317–326CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kulkarni O, Eulberg D, Selve N, Zoellner S, Allam R, Pawar RD, Pfeiffer S, Segerer S, Klussmann S, Anders HJ (2009) Anti-Ccl2 Spiegelmer Permits 75% Dose Reduction of Cyclophosphamide to Control Diffuse Proliferative Lupus Nephritis and Pneumonitis in MRL-Fas(lpr) Mice. J Pharmacol Exp Ther 328:371–377CrossRefPubMedGoogle Scholar
  22. 22.
    Vielhauer V, Kulkarni O, Reichel CA, Anders HJ (2010) Targeting the recruitment of monocytes and macrophages in renal disease. Semin in Nephrol 30:318–333CrossRefGoogle Scholar
  23. 23.
    King IL, Dickendesher TL, Segal BM (2009) Circulating Ly-6C + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113:3190–3197CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lucas T, Waisman A, Krieg T, Eming S (2010) Differential roles of macrophages in diverse phases of skin repair. Wound Repair Regen 18:A88-AGoogle Scholar
  25. 25.
    Miao M, Niu Y, Xie T, Yuan B, Qing C, Lu S (2012) Diabetes-impaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen 20:203 – 13CrossRefPubMedGoogle Scholar
  26. 26.
    Kawao N, Nagai N, Tamura Y, Okada K, Yano M, Suzuki Y, Umemura K, Ueshima S, Matsuo O (2011) Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice. Thromb Haemost 105:892–900CrossRefPubMedGoogle Scholar
  27. 27.
    Bowles AC, Wise RM, Gerstein BY, Thomas RC, Ogelman R, Febbo I, Bunnell BA (2017) Immunomodulatory effects of adipose stromal vascular fraction cells promote alternative activation macrophages to repair tissue damage. Stem CellsGoogle Scholar
  28. 28.
    Nathan C (2002) Points of control in inflammation. Nature 420:846–852CrossRefPubMedGoogle Scholar
  29. 29.
    Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targ Inflamm Allergy 4:281–286CrossRefGoogle Scholar
  30. 30.
    Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191–1197CrossRefPubMedGoogle Scholar
  31. 31.
    Shi JL, Aisaki K, Ikawa Y, Wake K (1998) Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 153:515–525CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Ren F, Duan ZP, Cheng Q, Shen XD, Gao F, Bai L, Liu J, Busuttil RW, Kupiec-Weglinski JW, Zhai Y (2011) Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism. Hepatology 54:687–696CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TRDJ, Reedquist KA, Tak PP, Baeten DLP (2012) Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 375:196–206CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Agnes S. Klar
    • 1
    • 3
    Email author
  • Katarzyna Michalak-Mićka
    • 1
    • 3
  • Thomas Biedermann
    • 1
    • 3
  • Claudia Simmen-Meuli
    • 4
  • Ernst Reichmann
    • 1
    • 3
  • Martin Meuli
    • 2
    • 3
  1. 1.Tissue Biology Research UnitUniversity Children’s Hospital ZurichZurichSwitzerland
  2. 2.Department of SurgeryUniversity Children’s Hospital ZurichZurichSwitzerland
  3. 3.Children’s Research CenterUniversity Children’s Hospital ZurichZurichSwitzerland
  4. 4.Department of Plastic, Reconstructive, Esthetical and Hand SurgeryKantonsspital AarauAarauSwitzerland

Personalised recommendations